Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
Ngwube A, Hanson IC, Orange J, Rider NL, Seeborg F, Shearer W, Noroski L, Nicholas S, Forbes L, Leung K, Sasa G, Naik S, Hegde M, Omer B, Ahmed N, Allen C, Gottschalk S, Wu MF, Liu H, Brenner M, Heslop H, Krance R, Martinez C. Ngwube A, et al. Among authors: krance r. Biol Blood Marrow Transplant. 2018 Mar;24(3):537-541. doi: 10.1016/j.bbmt.2017.11.019. Epub 2017 Nov 28. Biol Blood Marrow Transplant. 2018. PMID: 29196075 Free article. Clinical Trial.
Gene transfer and bone marrow transplantation.
Brenner MK, Heslop HE, Rill D, Li C, Nilson T, Roberts M, Smith C, Krance R, Rooney C. Brenner MK, et al. Among authors: krance r. Cold Spring Harb Symp Quant Biol. 1994;59:691-7. doi: 10.1101/sqb.1994.059.01.080. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587132 No abstract available.
BMT beats autoimmune disease.
Krance R, Brenner M. Krance R, et al. Nat Med. 1998 Feb;4(2):153-5. doi: 10.1038/nm0298-153. Nat Med. 1998. PMID: 9461184 No abstract available.
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Among authors: krance r. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.
Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector.
Brenner MK, Heslop H, Krance R, Horowitz M, Strother D, Nuchtern J, Grilley B, Martingano E, Cooper K. Brenner MK, et al. Among authors: krance r. Hum Gene Ther. 2000 Jul 1;11(10):1477-88. doi: 10.1089/10430340050057549. Hum Gene Ther. 2000. PMID: 10910144 Clinical Trial. No abstract available.
Tacrolimus clearance is age-dependent within the pediatric population.
Przepiorka D, Blamble D, Hilsenbeck S, Danielson M, Krance R, Chan KW. Przepiorka D, et al. Among authors: krance r. Bone Marrow Transplant. 2000 Sep;26(6):601-5. doi: 10.1038/sj.bmt.1702588. Bone Marrow Transplant. 2000. PMID: 11041564 Clinical Trial.
199 results